New drug - Relistor
Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more
Asked when the BMA meetings about extended hours were, no one was sure. The LMC executive officer said that a representative had been invited but had declined to come; obviously the most important issue for me as a GP in 20 years was not important to the BMA.
It was then pointed out that the BMA represents all doctors and that many of our hospital colleagues simply did not support us, so we were unlikely to receive decisive support from the BMA.
At first I was unwilling to believe this, but now I have been forced to change my mind.
I was hoping the BMA would stand its ground and stand up to the government. I was hoping that it would collect a determination from all doctors never to open for extended hours while the government pursues its blame-and-bully approach. I was hoping that we, like the police, would be marching on Downing Street to hand in our petition of 'no confidence' in the government.
No such luck. We have been left to fight on our own.
Dr David Jewson, Loughborough.
Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more
Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more
The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more
Comments
Only registered users may comment. Log in now or register for a free account.